Friday, August 7, 2009

Two Technologies one Company, Best Deal on the OTC.

AlumiFuel Power Corporation, formerly known as Inhibiton Therapeutics, Inc., recently acquired the wholly owned operating subsidiary AlumiFuel Power, Inc., a Philadelphia-based early production stage alternative energy company that generates hydrogen gas and steam for multiple niche applications requiring on-site, on-demand fuel sources. The Company also has been conducting biotechnology research, development and potential commercialization of technologies and products for new cancer therapeutic agents and cancer fighting drugs called targeted therapies.

AFPW.OB is clearly a company on the move, recent press releases tell of quad tripling of laboratory space. First product to begin initial production. The hiring of new investor relations. The strong management and numerous niche markets make Alumifuel Power Corp a very attractive investment.

Want More? Check out the new Investor Relations website -http://irgnews.com/coi/AFPW

Web-site- http://www.alumifuelpowerinc.com/